SciELO - Scientific Electronic Library Online

 
vol.38 número2Modulación de la diferenciación de células dendríticas por antígenos tumorales pulmonares índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Colombiana de Ciencias Químico - Farmacéuticas

versión impresa ISSN 0034-7418versión On-line ISSN 1909-6356

Resumen

SANABRIA ROJAS, Andrea; MARTINEZ, José Ignacio  y  DIAZ ROJAS, Jorge Augusto. Colon cancer: Analysis of disease cost to III and IV stages in Cansercoop IPS. Rev. colomb. cienc. quim. farm. [online]. 2009, vol.38, n.2, pp.193-214. ISSN 0034-7418.

The cancer colon has an increased incidence in Colombia and is a leading causes of mortality and morbidity in this group of diseases with a high economic and emotional burden, from the standpoint of economic impact there is little information in the Colombian context, for this reason, this work makes a case study in a health institution providing services, applying the methodology of "Cost of Illness" based on the prevalence of disease. Aim: To estimate the whole costs, both direct and indirect to cancer colon; establishing a distribution resources to III and IV stages. Method: analysis cost of Illness was used in patients were diagnosed as having both III and IV stages with cancer colon, from January 2005 to October 2007; checking a base data in Cansercoop IPS. Results: 79 people were identified, 44 (III stage) and 35 (IV stage), 59.9% of all of them are women up to 60 years old and 58.2% belong to Salud Total. The total cost was $ 348.254.762, 98.4% were direct costs and 1.59% were indirect costs. Average cost for each patient was $ 1.700.816 (49.288-11.529.013), III stage and $ 7.653.742 (13.523-70.354.423), IV stage. 65.66% are medicines. Conclusions: the total costs, both III and IV stages were $ 77.143.347 and $ 271.111.415 in III stage and $182.570.717 in IV stage. This analysis can be considered as a preliminary study; however it means a step to subsequent economic health assessments.

Palabras clave : colon cancer; analysis "cost of illness"; directs costs; indirect costs; total costs.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons